TheraRadar

Pharma Intelligence, Simplified

← All Targets

Calcium Channels

2 drugs
Cardiovascular
Market Leader
EXFORGE
Novartis
3
approved indications
2
Approved Drugs
1
Companies
3
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (1 companies)
All 2 approved drugs
Therapeutic area breakdown
Full indication list (3 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Novartis 2 drugs

By Therapeutic Area

Cardiovascular 2 drugs